Chemoradiotherapy for Recurrent T1G3 Bladder Cancer
To evaluate the short term results of chemoradiation in case of T1G3 BC after BCG failure.
Bladder Cancer
COMBINATION_PRODUCT: chemoradiation
Result of chemoradiation for recurrentT1G3 BC after BCG failure, treatment of 20 patients with recurrent T1G3

BC by chemoradiation to see efficacy and safety .and to reduce the number of recurrent cases and improve survival., followup within two years
Non- muscle invasive bladder cancer (NMIBC) is a heterogeneous group of cancers. For most urologists the treatment of T1G3 tumor poses a dilemma of management.The spectrum of clinical behavior includes; T1 lesions that will not progress however T1G3 may be potentially lethal, associated with metastatic disease at the time of presentation.

The major goal of treatment for T1G3 BC should be bladder preservation whenever possible.

Intravesical therapy with Bacille Calmette Guerin (BCG) may decrease the recurrence rate by compared with transurethral resection of bladder tumor (TURBT) alone.